$IZEA
IZEA Worldwide, Inc.

2022 Q2 Form 10-Q Financial Statement

#000149523122000099 Filed on May 16, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q1
Revenue $12.58M $8.890M $5.528M
YoY Change 96.01% 60.82% 27.83%
Cost Of Revenue $7.212M $5.180M $2.458M
YoY Change 124.76% 110.75% 23.61%
Gross Profit $5.365M $3.711M $3.070M
YoY Change 67.25% 20.85% 31.43%
Gross Profit Margin 42.66% 41.74% 55.54%
Selling, General & Admin $5.669M $6.023M $4.613M
YoY Change 14.23% 30.55% 17.06%
% of Gross Profit 105.66% 162.31% 150.26%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $138.5K $138.8K $365.5K
YoY Change -61.94% -62.02% -27.08%
% of Gross Profit 2.58% 3.74% 11.91%
Operating Expenses $5.669M $6.023M $4.613M
YoY Change 14.23% 30.55% 17.06%
Operating Profit -$442.2K -$2.451M -$1.909M
YoY Change -79.13% 28.42% -70.21%
Interest Expense $815.00 $965.00 $13.79K
YoY Change -90.67% -93.0% 108.42%
% of Operating Profit
Other Income/Expense, Net $272.3K -$25.25K $15.68K
YoY Change -86.11% -261.01% -135.35%
Pretax Income -$169.9K -$2.476M -$1.990M
YoY Change 7.25% 24.43% -67.69%
Income Tax
% Of Pretax Income
Net Earnings -$169.9K -$2.476M -$1.893M
YoY Change 7.25% 30.81% -70.65%
Net Earnings / Revenue -1.35% -27.85% -34.24%
Basic Earnings Per Share
Diluted Earnings Per Share -$2.731K -$39.90K -$35.33K
COMMON SHARES
Basic Shares Outstanding 62.23M shares 62.18M shares 59.13M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $44.42M $72.56M $65.47M
YoY Change -40.77% 10.83% 1062.88%
Cash & Equivalents $11.35M $72.56M $65.47M
Short-Term Investments $33.07M
Other Short-Term Assets $17.98K $19.18K $48.34K
YoY Change -71.33% -60.32% 30.31%
Inventory
Prepaid Expenses $2.880M $4.067M $387.0K
Receivables $7.579M $7.260M $4.072M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $54.89M $83.91M $69.97M
YoY Change -33.23% 19.91% 594.09%
LONG-TERM ASSETS
Property, Plant & Equipment $92.07K $151.4K $219.6K
YoY Change -52.49% -31.04% -30.77%
Goodwill $4.017M $4.017M $4.017M
YoY Change 0.0% 0.0% 0.0%
Intangibles $72.54K $150.3K $288.9K
YoY Change 0.43% -47.98% -76.82%
Long-Term Investments $25.85M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $31.12M $5.332M $5.881M
YoY Change 463.27% -9.35% -18.33%
TOTAL ASSETS
Total Short-Term Assets $54.89M $83.91M $69.97M
Total Long-Term Assets $31.12M $5.332M $5.881M
Total Assets $86.01M $89.24M $75.85M
YoY Change -1.96% 17.64% 338.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.802M $1.858M $2.024M
YoY Change -5.53% -8.18% 40.03%
Accrued Expenses $2.421M $2.087M $1.681M
YoY Change 15.45% 24.19% 4.74%
Deferred Revenue $9.531M $12.77M $6.639M
YoY Change 16.26% 92.38% 28.21%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $65.36K $66.28K $1.830M
YoY Change 108.75% -96.38% 53.78%
Total Short-Term Liabilities $13.79M $16.75M $12.14M
YoY Change 12.97% 37.96% 29.29%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $170.0K
YoY Change -100.0% -100.0% 142.86%
Other Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $170.0K
YoY Change -100.0% -100.0% 142.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.79M $16.75M $12.14M
Total Long-Term Liabilities $0.00 $0.00 $170.0K
Total Liabilities $13.79M $16.75M $12.31M
YoY Change 12.36% 36.02%
SHAREHOLDERS EQUITY
Retained Earnings -$76.28M -$76.11M -$72.39M
YoY Change 5.15% 5.14% 8.96%
Common Stock $6.221K $6.211K $5.912K
YoY Change 0.65% 5.06% 70.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $72.23M $72.49M $63.54M
YoY Change
Total Liabilities & Shareholders Equity $86.01M $89.24M $75.85M
YoY Change -1.96% 17.64% 338.89%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$169.9K -$2.476M -$1.893M
YoY Change 7.25% 30.81% -70.65%
Depreciation, Depletion And Amortization $138.5K $138.8K $365.5K
YoY Change -61.94% -62.02% -27.08%
Cash From Operating Activities -$1.840M -$2.727M -$829.7K
YoY Change -20.41% 228.65% -38.47%
INVESTING ACTIVITIES
Capital Expenditures -$180.1K -$128.6K -$20.00K
YoY Change 1758.62% 542.9%
Acquisitions
YoY Change
Other Investing Activities -$59.18M $660.00 $10.00K
YoY Change 5479671.3% -93.4%
Cash From Investing Activities -$59.36M -$127.9K -$13.22K
YoY Change 551075.86% 867.79% -74.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.17K -$19.73K $33.26M
YoY Change -100.09% -100.06% 2794.5%
NET CHANGE
Cash From Operating Activities -1.840M -$2.727M -$829.7K
Cash From Investing Activities -59.36M -$127.9K -$13.22K
Cash From Financing Activities -10.17K -$19.73K $33.26M
Net Change In Cash -61.21M -$2.874M $32.42M
YoY Change -738.98% -108.87% -13058.4%
FREE CASH FLOW
Cash From Operating Activities -$1.840M -$2.727M -$829.7K
Capital Expenditures -$180.1K -$128.6K -$20.00K
Free Cash Flow -$1.660M -$2.598M -$809.7K
YoY Change -27.9% 220.88% -39.95%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001495231
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
62225449 shares
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62112054 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62044883 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62112054 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62044883 shares
CY2022Q1 izea Contractassetsandcontractliabilitieslengthofagreementwithcustomers
Contractassetsandcontractliabilitieslengthofagreementwithcustomers
P1Y
CY2022Q1 izea Defined Contribution Plan Employers Matching Contribution Years Of Service
DefinedContributionPlanEmployersMatchingContributionYearsOfService
P2Y
CY2022Q1 izea Defined Contribution Plan Employers Matching Contribution Years Of Service
DefinedContributionPlanEmployersMatchingContributionYearsOfService
P2Y
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-37703
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
IZEA WORLDWIDE, INC.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
37-1530765
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1317 Edgewater Dr.
CY2022Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
# 1880
CY2022Q1 dei Entity Address Address Line3
EntityAddressAddressLine3
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Orlando
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32804
CY2022Q1 dei City Area Code
CityAreaCode
(407)
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
674-6911
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2022Q1 dei Trading Symbol
TradingSymbol
IZEA
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
62225449 shares
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72558846 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
75433295 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7259891 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7599103 USD
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4067328 USD
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2257382 USD
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
19183 USD
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
100522 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
83905248 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
85390302 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
151402 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
155185 USD
CY2022Q1 us-gaap Goodwill
Goodwill
4016722 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-76109811 USD
CY2021Q4 us-gaap Goodwill
Goodwill
4016722 USD
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
150287 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
213263 USD
CY2022Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1013130 USD
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1019600 USD
CY2022Q1 us-gaap Assets
Assets
89236789 USD
CY2021Q4 us-gaap Assets
Assets
90795072 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1858215 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2086892 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2087281 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2502882 USD
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
12772552 USD
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
11338095 USD
CY2022Q1 us-gaap Notes Payable Current
NotesPayableCurrent
31985 USD
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73633568 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
72486756 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
74825135 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
89236789 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
90795072 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8890336 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5528166 USD
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
5179724 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
16750033 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
15927869 USD
CY2022Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0 USD
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
10420 USD
CY2022Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
0 USD
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
31648 USD
CY2022Q1 us-gaap Liabilities
Liabilities
16750033 USD
CY2021Q4 us-gaap Liabilities
Liabilities
15969937 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
6211 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
6205 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
148590356 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
148452498 USD
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
2457785 USD
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2520343 USD
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2078323 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3502435 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2535147 USD
CY2022Q1 izea Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.04 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
138829 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
365529 USD
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
11341331 USD
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
7436784 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2450995 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1908618 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
965 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
13793 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-24283 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
29474 USD
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-25248 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
15681 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2476243 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1892937 USD
CY2022Q1 izea Weighted Average Common Shares Outstanding Basic And Diluted
WeightedAverageCommonSharesOutstandingBasicAndDiluted
62065768 USD
CY2021Q1 izea Weighted Average Common Shares Outstanding Basic And Diluted
WeightedAverageCommonSharesOutstandingBasicAndDiluted
56334219 USD
CY2021Q1 izea Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.03 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
74825135 USD
CY2022Q1 izea Stock Issued During Period Value Employee Purchase Price Plan And Stock Options Exercised
StockIssuedDuringPeriodValueEmployeePurchasePricePlanAndStockOptionsExercised
6700 USD
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
31223 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
117192 USD
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
17251 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2476243 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
72486756 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
31928189 USD
CY2021Q1 izea Stock Issued During Period Sale Of Securityvalue
StockIssuedDuringPeriodSaleOfSecurityvalue
34358012 USD
CY2021Q1 izea Stock Issued During Period Value Employee Purchase Price Plan And Stock Options Exercised
StockIssuedDuringPeriodValueEmployeePurchasePricePlanAndStockOptionsExercised
2144 USD
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
34696 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
746957 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
197986 USD
CY2021Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
341576 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1892937 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
63539557 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2476243 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
134322 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1892937 USD
CY2022Q1 us-gaap Depreciation
Depreciation
32933 USD
CY2021Q1 us-gaap Depreciation
Depreciation
32486 USD
CY2022Q1 izea Amortizationofsoftwaredevelopmentcostsandotherintangibleassets
Amortizationofsoftwaredevelopmentcostsandotherintangibleassets
105896 USD
CY2021Q1 izea Amortizationofsoftwaredevelopmentcostsandotherintangibleassets
Amortizationofsoftwaredevelopmentcostsandotherintangibleassets
333043 USD
CY2022Q1 izea Impairment Of Digital Assets
ImpairmentOfDigitalAssets
62976 USD
CY2021Q1 izea Impairment Of Digital Assets
ImpairmentOfDigitalAssets
0 USD
CY2022Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
663 USD
CY2021Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
7914 USD
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
117192 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
197986 USD
CY2022Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
31223 USD
CY2021Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
34696 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-339213 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1135265 USD
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1728607 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-228677 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-287213 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-416505 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-245077 USD
CY2022Q1 izea Changeincontractwithcustomerliability
Changeincontractwithcustomerliability
1434456 USD
CY2021Q1 izea Changeincontractwithcustomerliability
Changeincontractwithcustomerliability
4280 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2726806 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-829707 USD
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
29150 USD
CY2021Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
22109 USD
CY2022Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
663 USD
CY2021Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
8892 USD
CY2022Q1 izea Payments To Proceeds From Developed Software
PaymentsToProceedsFromDevelopedSoftware
99426 USD
CY2021Q1 izea Payments To Proceeds From Developed Software
PaymentsToProceedsFromDevelopedSoftware
0 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-127913 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13217 USD
CY2022Q1 izea Proceeds From The Sale Of Securities Financing Activities
ProceedsFromTheSaleOfSecuritiesFinancingActivities
0 USD
CY2021Q1 izea Proceeds From The Sale Of Securities Financing Activities
ProceedsFromTheSaleOfSecuritiesFinancingActivities
34358012 USD
CY2022Q1 izea Proceeds From Employee Stock Purchase Plan And Stock Options Exercised
ProceedsFromEmployeeStockPurchasePlanAndStockOptionsExercised
6700 USD
CY2021Q1 izea Proceeds From Employee Stock Purchase Plan And Stock Options Exercised
ProceedsFromEmployeeStockPurchasePlanAndStockOptionsExercised
2144 USD
CY2022Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
9179 USD
CY2021Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
8336 USD
CY2022Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
CY2021Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
746957 USD
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
17251 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
341576 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19730 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
33263287 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2874449 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
32420363 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75433295 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33045225 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72558846 USD
CY2022Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65465588 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
1894 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
4792 USD
CY2022Q1 us-gaap Stock Issued1
StockIssued1
125000 USD
CY2021Q1 us-gaap Stock Issued1
StockIssued1
147329 USD
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which COVID-19 impacts the Company’s business and financial results will depend on numerous evolving factors including, but not limited to the magnitude and duration of COVID-19, the extent to which it impacts worldwide macroeconomic conditions, the speed of the anticipated recovery, access to capital markets, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of March 31, 2022, and through the date of the filing of this Quarterly Report on Form 10-Q. The accounting matters assessed included but were not limited to estimates related to revenue, the accounting for potential liabilities and accrued expenses, the assumptions utilized in valuing stock-based compensation issued for services, the realization of deferred tax assets, and assessments of impairment related to long-lived assets, intangible assets, and goodwill. The Company’s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in additional material impacts on the Company’s consolidated financial statements in future reporting periods.</span></div>Despite the Company’s efforts, the ultimate impact of COVID-19 depends on factors beyond the Company’s knowledge or control, including the duration and severity of the outbreak, as well as third-party actions taken to contain its spread and mitigate its public health effects. As a result, the Company is unable to estimate the full extent to which COVID-19 will negatively impact its financial results or liquidity.
CY2022Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
71700000 USD
CY2021Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
74900000 USD
CY2022Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
7232501 USD
CY2022Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
27390 USD
CY2021Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
7577177 USD
CY2021Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
21926 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
155000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
155000 USD
CY2022Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentrations of credit risk for accounts receivable have typically been limited because a large number of geographically diverse customers make up the Company’s customer base, thus spreading the trade credit risk. However, the Company’s addition of SaaS customers has increased credit exposure on certain customers who carry significant credit balances related to their marketplace spend. The Company controls credit risk through credit approvals, credit limits, and monitoring procedures. The Company performs credit evaluations of its customers but generally does not require collateral to support accounts receivable. The Company currently has two customers that each accounted for more than 10% of total accounts receivable at March 31, 2022, and zero customers that accounted for more than 10% of total accounts receivable at December 31, 2021. The Company had three customers that each accounted for more than 10% of its gross billings during the three months ended March 31, 2022, and no customers that accounted for more than 10% of its gross billings during the three months ended March 31, 2021.
CY2022Q1 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1 lease
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
62976 USD
CY2022Q1 izea Amortizationperiodofsoftwaredevelopmentcosts
Amortizationperiodofsoftwaredevelopmentcosts
P5Y
CY2022Q1 izea Leaseterm
Leaseterm
P12M
CY2022Q1 izea Leaseterm
Leaseterm
P12M
CY2022Q1 izea Invoicepaymentterms
Invoicepaymentterms
P30D
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
844907 USD
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
816330 USD
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
693505 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
661145 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
151402 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
155185 USD
CY2021Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2022Q1 us-gaap Depreciation
Depreciation
32933 USD
CY2022Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
150287 USD
CY2021Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
213263 USD
CY2022Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
6361756 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6211469 USD
CY2021Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
6424732 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6211469 USD
CY2022Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
150287 USD
CY2021Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
213263 USD
CY2022Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
6361756 USD
CY2021Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
6424732 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6211469 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6211469 USD
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
150287 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
213263 USD
CY2022Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
62976 USD
CY2022Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
150287 USD
CY2022Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2022Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
3136237 USD
CY2021Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
3036810 USD
CY2022Q1 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
2123107 USD
CY2021Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
2017210 USD
CY2022Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1013130 USD
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1019600 USD
CY2022Q1 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
99426 USD
CY2021Q1 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
0 USD
CY2022Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
3136237 USD
CY2022Q1 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
1849776 USD
CY2021Q4 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
2251284 USD
CY2022Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
68296 USD
CY2021Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
76079 USD
CY2022Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
134917 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
142131 USD
CY2022Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
2087281 USD
CY2021Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
2502882 USD
CY2021Q1 us-gaap Line Of Credit Facility Collateral Fees Amount
LineOfCreditFacilityCollateralFeesAmount
20000 USD
CY2021Q1 izea Line Of Credit Facility Annual Due Dilligence Fee
LineOfCreditFacilityAnnualDueDilligenceFee
1000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
66277 USD
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
66277 USD
CY2022Q1 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
CY2022Q1 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
CY2022Q1 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.08
CY2022Q1 us-gaap Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage
DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage
0.20
CY2022Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
117567 USD
CY2021Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
62662 USD
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021 izea Numberofindependentdirectors
Numberofindependentdirectors
6 directors
CY2022Q1 izea Numberofindependentdirectors
Numberofindependentdirectors
5 directors
CY2022Q1 izea Percentageofindividualownershipofcommonstock
Percentageofindividualownershipofcommonstock
0.10
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6700 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 USD
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1510 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
4651
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
708393 USD
CY2022Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
68656 USD
CY2021Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
52407 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2476243 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1892937 USD
CY2022Q1 izea Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
62065768 USD
CY2021Q1 izea Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
56334219 USD
CY2022Q1 izea Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.04 USD
CY2021Q1 izea Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.03 USD
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2304332 shares
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2422394 shares
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8890336 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5528166 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8890336 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5528166 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7259891 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7599103 USD
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
12772552 USD
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
11338095 USD
CY2022Q1 izea Contract Length For Sales Commissions Payment
ContractLengthForSalesCommissionsPayment
1

Files In Submission

Name View Source Status
0001495231-22-000099-index-headers.html Edgar Link pending
0001495231-22-000099-index.html Edgar Link pending
0001495231-22-000099.txt Edgar Link pending
0001495231-22-000099-xbrl.zip Edgar Link pending
a101firstamendmenttoexecut.htm Edgar Link pending
a102firstamendmenttotheexe.htm Edgar Link pending
a103firstamendmenttoexecut.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
izea-20220331.htm Edgar Link pending
izea-20220331.xsd Edgar Link pending
izea-20220331_cal.xml Edgar Link unprocessable
izea-20220331_def.xml Edgar Link unprocessable
izea-20220331_htm.xml Edgar Link completed
izea-20220331_lab.xml Edgar Link unprocessable
izea-20220331_pre.xml Edgar Link unprocessable
izea220331ex311.htm Edgar Link pending
izea220331ex312.htm Edgar Link pending
izea220331ex321.htm Edgar Link pending
izea220331ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending